Facebook
X
LinkedIn
ForwardPlenary Session I
This session reviews the latest science in the field of radiopharmaceutical therapy.
Target Audience
This meeting was designed to meet the interests of medical oncologists, radiation oncologists, physicists, nurses, diagnostic radiologists, radiation therapists, radiation dosimetrists, specialists, nuclear physicians and practice administrators.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
Identify the latest science in the field of radiopharmaceutical therapy.
Speakers
- Neil Kanth Taunk, MD, MS, University of Pennsylvania;
- Jacqueline E. Zoberi, PhD, Washington University School of Medicine
- Mohammad Arfat Ganiyani, MBBS, Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami
- David Adam, PhD, MS, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore
- Savita V. Dandapani, MD, PhD, Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California
- Mustafa Basree, DO, MS, Department of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, Wisconsin
- Robert Hobbs, PhD, DABR, FAAPM, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore
- Savita V. Dandapani, MD, PhD, Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California
- Gowtham Murugesan, PhD, BAMF Health, Grand Rapids, Michigan
- Daniel Rosen, MD, PhD, Department of Radiation Oncology, Brigham and Women’s / Dana-Farber Cancer Center, Harvard Medical School, Boston
- Mai Anh Huynh, MD, PhD, Department of Radiation Oncology, Brigham and Women’s / Dana-Farber Cancer Center, Harvard Medical School, Boston
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.